Skip to content
PICO Portalanswers from OpenAlex

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer

PaperCitations, authors & open-access status

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer have?

PICO Portalcitation count

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer has 90 citations in the OpenAlex counts PICO Portal stores.

When was Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer published?

PICO Portalyear

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer has 2019 year in the PICO Portal index.

What is the open-access status of Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer?

PICO Portaloa status

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer has closed oa status in the PICO Portal index.

What is the DOI of Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer?

PICO Portaldoi

The DOI for Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer is on the source record.

What is the PMID of Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer?

PICO Portalpmid

The PMID for Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer is on the source record.

What is the OpenAlex record for Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer?

PICO Portalopenalex

The OpenAlex for Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial